A Randomized Prospective Clinical Trial of Fel d 1 Peptide Immunotherapy

计划入组 39 人 · 首次发布于 2014 年 12 月 8 日

Analysis of Fel d 1-specific T Cells After Airway Allergen Challenge in Asthma

计划入组 38 人 · 首次发布于 2012 年 6 月 6 日

A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy

计划入组 570 人 · 首次发布于 2026 年 6 月 30 日

GFD

D-20140305-1

D-JNKI-1

C₁₆₄H₂₈₅N₆₅O₄₁

NHI-1

United States

Xi'an No.1 Hospital

China

ALPHA-1 FOUNDATION, INC.

United States

Real-World Study Confirms Effectiveness of Cat Allergen Immunotherapy for Respiratory Allergies

D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01

India Selects First Biotech Startups Under ₹1 Trillion R&D Initiative as Transparency Concerns Linger